BMS-844203 (CT322)

BMS-844203 · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-844203 (CT322), covering 2012-02-07 to 2012-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Japanese Phase 1 Study of BMS-844203 (CT322) [Phase 1]